This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Rite Aid Names Yong Choe Vice President Of Federal Affairs And Public Policy

Rite Aid Corporation (NYSE: RAD) announced today that Yong Choe, a government affairs professional with extensive knowledge of health care and the retail pharmacy industry, has joined Rite Aid as Vice President of Federal Affairs and Public Policy.

In this position, Choe will be responsible for developing and executing policy and strategy relating to federal and state health care issues as well as identifying and addressing federal health program legislation and trends that could affect Rite Aid’s business strategy and operations. Choe is based in Washington, D.C., and will report to Rite Aid’s Executive Vice President of Pharmacy, Robert Thompson.

“Yong’s experience in public policy, coupled with his knowledge of the retail pharmacy industry, makes him a true asset to Rite Aid’s government affairs team,” said Thompson. “We are excited to have him on board, especially given the ever-changing health care landscape and the many new health care laws set to take place this year. We look forward to his many contributions as we continue in our mission to deliver a superior experience to our pharmacy customers.”

Prior to joining Rite Aid, Choe served as the Director of Business Outreach and Member Services for the Republican Study Committee, chaired by U.S. Rep. Jim Jordan of Ohio. Between 2003 and 2010, Choe was with the National Association of Chain Drug Stores (NACDS), serving in various roles within its government affairs division. Choe began his career on Capitol Hill working as a legislative clerk for the U.S. House Energy and Commerce Committee.

Choe earned a Bachelor of Arts degree from DePauw University.

Rite Aid Corporation is one of the nation’s leading drugstore chains with more than 4,600 stores in 31 states and the District of Columbia and fiscal 2012 annual revenues of $26.1 billion. Information about Rite Aid, including corporate background and press releases, is available through the company’s website at www.riteaid.com.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
SYM TRADE IT LAST %CHG

Markets

DOW 17,619.51 +23.16 0.13%
S&P 500 2,063.12 +5.48 0.27%
NASDAQ 4,986.8670 +28.3990 0.57%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs